Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 104

1.

Short and long-term responsiveness to low dose GH in adult Growth Hormone Deficiency (GHD): role of GH receptor (GHR) polymorphism.

Bianchi A, Giampietro A, Tartaglione L, Chiloiro S, Gentilella R, Bima C, Anile C, Olivi A, Pontecorvi A, De Marinis L.

J Neuroendocrinol. 2019 Feb 3:e12692. doi: 10.1111/jne.12692. [Epub ahead of print]

PMID:
30712287
2.

Immune checkpoint blockade for Merkel cell carcinoma: actual findings and unanswered questions.

Gallo M, Guarnotta V, De Cicco F, Rubino M, Faggiano A, Colao A; NIKE Group.

J Cancer Res Clin Oncol. 2019 Feb;145(2):429-443. doi: 10.1007/s00432-019-02839-w. Epub 2019 Jan 7. Review.

PMID:
30617553
3.

MWCNTs-Supported Pd(II) Complexes with High Catalytic Efficiency in Oxygen Reduction Reaction in Alkaline Media.

Passaponti M, Savastano M, Clares MP, Inclán M, Lavacchi A, Bianchi A, García-España E, Innocenti M.

Inorg Chem. 2018 Oct 24. doi: 10.1021/acs.inorgchem.8b02695. [Epub ahead of print]

PMID:
30354096
4.

Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study.

Rindi G, Klersy C, Albarello L, Baudin E, Bianchi A, Buchler MW, Caplin M, Couvelard A, Cros J, de Herder WW, Delle Fave G, Doglioni C, Federspiel B, Fischer L, Fusai G, Gavazzi F, Hansen CP, Inzani F, Jann H, Komminoth P, Knigge UP, Landoni L, La Rosa S, Lawlor RT, Luong TV, Marinoni I, Panzuto F, Pape UF, Partelli S, Perren A, Rinzivillo M, Rubini C, Ruszniewski P, Scarpa A, Schmitt A, Schinzari G, Scoazec JY, Sessa F, Solcia E, Spaggiari P, Toumpanakis C, Vanoli A, Wiedenmann B, Zamboni G, Zandee WT, Zerbi A, Falconi M.

Neuroendocrinology. 2018;107(4):375-386. doi: 10.1159/000494355. Epub 2018 Oct 9.

5.

Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study.

Chiloiro S, Tartaglione T, Capoluongo ED, Angelini F, Arena V, Giampietro A, Bianchi A, Zoli A, Pontecorvi A, Colosimo C, De Marinis L.

J Clin Endocrinol Metab. 2018 Oct 1;103(10):3877-3889. doi: 10.1210/jc.2018-01021.

PMID:
30085134
6.

Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis.

Tartaglione T, Chiloiro S, Laino ME, Giampietro A, Gaudino S, Zoli A, Bianchi A, Pontecorvi A, Colosimo C, De Marinis L.

Pituitary. 2018 Aug;21(4):414-424. doi: 10.1007/s11102-018-0892-4.

PMID:
29752700
7.

Network Formation via Anion Coordination: Crystal Structures Based on the Interplay of Non-Covalent Interactions.

Savastano M, Bazzicalupi C, Mariani P, Bianchi A.

Molecules. 2018 Mar 3;23(3). pii: E572. doi: 10.3390/molecules23030572.

8.

Correction to: Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly.

Chiloiro S, Mazziotti G, Giampietro A, Bianchi A, Frara S, Mormando M, Pontecorvi A, Giustina A, De Marinis L.

Pituitary. 2018 Jun;21(3):309. doi: 10.1007/s11102-018-0878-2.

PMID:
29473124
9.

Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients.

Chiloiro S, Capoluongo ED, Tartaglione T, Bianchi A, Giampietro A, Angelini F, Arena V, Pontecorvi A, De Marinis L.

Clin Endocrinol (Oxf). 2018 May;88(5):692-699. doi: 10.1111/cen.13566. Epub 2018 Feb 26.

PMID:
29418012
10.

Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly.

Chiloiro S, Mazziotti G, Giampietro A, Bianchi A, Frara S, Mormando M, Pontecorvi A, Giustina A, De Marinis L.

Pituitary. 2018 Jun;21(3):302-308. doi: 10.1007/s11102-018-0873-7. Erratum in: Pituitary. 2018 Feb 23;:.

PMID:
29397538
11.

Acromegaly is associated with increased cancer risk: a survey in Italy.

Terzolo M, Reimondo G, Berchialla P, Ferrante E, Malchiodi E, De Marinis L, Pivonello R, Grottoli S, Losa M, Cannavo S, Ferone D, Montini M, Bondanelli M, De Menis E, Martini C, Puxeddu E, Velardo A, Peri A, Faustini-Fustini M, Tita P, Pigliaru F, Peraga G, Borretta G, Scaroni C, Bazzoni N, Bianchi A, Berton A, Serban AL, Baldelli R, Fatti LM, Colao A, Arosio M; Italian Study Group of Acromegaly.

Endocr Relat Cancer. 2017 Sep;24(9):495-504. doi: 10.1530/ERC-16-0553. Epub 2017 Jul 14.

12.

Cation, Anion and Ion-Pair Complexes with a G-3 Poly(ethylene imine) Dendrimer in Aqueous Solution.

Savastano M, Bazzicalupi C, Giorgi C, Gratteri P, Bianchi A.

Molecules. 2017 May 16;22(5). pii: E816. doi: 10.3390/molecules22050816.

13.

Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives.

Gallo M, Malandrino P, Fanciulli G, Rota F, Faggiano A, Colao A; NIKE Group.

J Cancer Res Clin Oncol. 2017 Jul;143(7):1209-1224. doi: 10.1007/s00432-017-2407-5. Epub 2017 Apr 12. Review.

PMID:
28405826
14.

Iodide and triiodide anion complexes involving anion-π interactions with a tetrazine-based receptor.

Savastano M, Bazzicalupi C, García C, Gellini C, López de la Torre MD, Mariani P, Pichierri F, Bianchi A, Melguizo M.

Dalton Trans. 2017 Apr 5;46(14):4518-4529. doi: 10.1039/c7dt00134g.

PMID:
28262880
15.

The treatment of hyperinsulinemic hypoglycaemia in adults: an update.

Davi MV, Pia A, Guarnotta V, Pizza G, Colao A, Faggiano A; NIKE Group.

J Endocrinol Invest. 2017 Jan;40(1):9-20. doi: 10.1007/s40618-016-0536-3. Epub 2016 Sep 13. Review.

PMID:
27624297
16.

Anion Complexes with Tetrazine-Based Ligands: Formation of Strong Anion-π Interactions in Solution and in the Solid State.

Savastano M, Bazzicalupi C, Giorgi C, García-Gallarín C, López de la Torre MD, Pichierri F, Bianchi A, Melguizo M.

Inorg Chem. 2016 Aug 15;55(16):8013-24. doi: 10.1021/acs.inorgchem.6b01138. Epub 2016 Jul 25.

PMID:
27454810
17.

An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Prospective Single-Center Experience.

Chiloiro S, Tartaglione T, Angelini F, Bianchi A, Arena V, Giampietro A, Mormando M, Sciandra M, Laino ME, De Marinis L.

Neuroendocrinology. 2017;104(3):280-290. doi: 10.1159/000446544. Epub 2016 May 11.

PMID:
27165294
18.

Predictive factors of response to mTOR inhibitors in neuroendocrine tumours.

Zatelli MC, Fanciulli G, Malandrino P, Ramundo V, Faggiano A, Colao A; NIKE Group.

Endocr Relat Cancer. 2016 Mar;23(3):R173-83. doi: 10.1530/ERC-15-0413. Epub 2015 Dec 14. Review.

PMID:
26666705
19.

Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study.

Iacovazzo D, Carlsen E, Lugli F, Chiloiro S, Piacentini S, Bianchi A, Giampietro A, Mormando M, Clear AJ, Doglietto F, Anile C, Maira G, Lauriola L, Rindi G, Roncaroli F, Pontecorvi A, Korbonits M, De Marinis L.

Eur J Endocrinol. 2016 Feb;174(2):241-50. doi: 10.1530/EJE-15-0832. Epub 2015 Nov 19.

PMID:
26586796
20.

Increased FGF23 serum level is associated with unstable carotid plaque in type 2 diabetic subjects with internal carotid stenosis.

Biscetti F, Straface G, Porreca CF, Bertoletti G, Vincenzoni C, Snider F, Stigliano E, Arena V, Angelini F, Pecorini G, Bianchi A, Landolfi R, Flex A.

Cardiovasc Diabetol. 2015 Oct 12;14:139. doi: 10.1186/s12933-015-0301-5.

Supplemental Content

Loading ...
Support Center